---
schema_version: "secwatch.filing_event.v1"
accession: "0001387131-23-009019"
form_type: "8-K"
ticker: "TNXP"
cik: "0001430306"
company_name: "Tonix Pharmaceuticals Holding Corp."
filed_at: "2023-07-28T23:59:59+00:00"
generated_at: "2026-06-12T22:54:54.434696+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Tonix prices $7M public offering of common stock and warrants to fund operations

## Summary
- Priced $7M public offering: 2.53M shares + pre-funded warrants for 4.47M shares + 7M common warrants at $1.00 per unit.
- Gross proceeds ~$7M; net proceeds for working capital, facility build-out, and product acquisition/licensing.
- Common warrants exercisable at $1.00/share, expire 5 years from issuance.
- Lock-up: directors/officers restricted from selling for 60 days post-closing.
- Closing expected August 1, 2023; A.G.P. and Brookline Capital Markets acting as placement agents.

## SEC filing metadata
- accession: 0001387131-23-009019
- form_type: 8-K
- ticker: TNXP
- cik: 0001430306
- company_name: Tonix Pharmaceuticals Holding Corp.
- filed_at: 2023-07-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1430306/000138713123009019/0001387131-23-009019-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1430306/000138713123009019/tnxp_8k-072423.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001387131-23-009019
- JSON: https://secwatch.observer/filing/0001387131-23-009019.json
- Plain text: https://secwatch.observer/filing/0001387131-23-009019.txt

## Key facts
- Material Agreements
  Tonix Pharmaceuticals Holding Corp. entered into Placement Agent Agreement with A.G.P./Alliance Global Partners and Brookline Capital Markets, a division of Arcadia Securities, LLC (the "Placement Agents") (effective 2023-07-27).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: A.G.P./Alliance Global Partners and Brookline Capital Markets, a division of Arcadia Securities, LLC (the "Placement Agents")
  - Effective: 2023-07-27
  source text: On July 27, 2023, the Company also entered into a placement agent agreement (the "Placement Agent Agreement") with A.G.P./Alliance Global Partners and Brookline Capital Markets, a division of Arcadia Securities, LLC (the "Placement Agents").
  evidence_url: https://www.sec.gov/Archives/edgar/data/1430306/000138713123009019/0001387131-23-009019-index.htm
- Material Agreements
  Tonix Pharmaceuticals Holding Corp. entered into Purchase Agreement with certain institutional investors (the "Purchasers") valued at $1.00 (effective 2023-07-27).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain institutional investors (the "Purchasers")
  - Value: $1.00
  - Effective: 2023-07-27
  source text: On July 27, 2023, Tonix Pharmaceuticals Holding Corp. (the "Company"), entered into a securities purchase agreement (the "Purchase Agreement") with certain institutional investors (collectively, the "Purchasers").
  evidence_url: https://www.sec.gov/Archives/edgar/data/1430306/000138713123009019/0001387131-23-009019-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.